Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease (2010)
- Authors:
- USP affiliated authors: FRANCO, DOUGLAS WAGNER - IQSC ; ZAMBONI, DARIO SIMÕES - FMRP ; SILVA, ROBERTO SANTANA DA - FCFRP ; SILVA, JOÃO SANTANA DA - FMRP
- Unidades: IQSC; FMRP; FCFRP
- DOI: 10.1111/j.1476-5381.2009.00576.x
- Subjects: DOENÇA DE CHAGAS (TRATAMENTO); QUÍMICA INORGÂNICA; QUÍMICA MÉDICA; TRYPANOSOMA CRUZI
- Language: Inglês
- Imprenta:
- Publisher place: Chichester
- Date published: 2010
- Source:
- Título do periódico: British Journal of Pharmacology
- ISSN: 0007-1188
- Volume/Número/Paginação/Ano: v. 160, n. 2, p. 270-282, 2010
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
GUEDES, Paulo M M et al. Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease. British Journal of Pharmacology, v. 160, n. 2, p. 270-282, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1476-5381.2009.00576.x. Acesso em: 01 out. 2024. -
APA
Guedes, P. M. M., Oliveira, F. S., Gutierrez, F. R. S., Silva, G. K. da, Rodrigues, G. J., Bendhack, L. M., et al. (2010). Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease. British Journal of Pharmacology, 160( 2), 270-282. doi:10.1111/j.1476-5381.2009.00576.x -
NLM
Guedes PMM, Oliveira FS, Gutierrez FRS, Silva GK da, Rodrigues GJ, Bendhack LM, Franco DW, Matta MADV, Zamboni DS, Silva RS da, Silva JS da. Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease [Internet]. British Journal of Pharmacology. 2010 ; 160( 2): 270-282.[citado 2024 out. 01 ] Available from: https://doi.org/10.1111/j.1476-5381.2009.00576.x -
Vancouver
Guedes PMM, Oliveira FS, Gutierrez FRS, Silva GK da, Rodrigues GJ, Bendhack LM, Franco DW, Matta MADV, Zamboni DS, Silva RS da, Silva JS da. Nitric oxide donor trans-'[RuCl([15]ane'N IND.4')NO]'POT.2+'as a possible therapeutic approach for chagas' disease [Internet]. British Journal of Pharmacology. 2010 ; 160( 2): 270-282.[citado 2024 out. 01 ] Available from: https://doi.org/10.1111/j.1476-5381.2009.00576.x - Ros-dependent NLRP3-inflammasome activation is critical for restriction of Leishmania amazonensis infection
- Critical role of ASC inflammasomes in host innate resistance to Trypanosoma cruzi infection
- NOD/RIP2 signaling contribute to development of a TH1 response and resistance against L. major infection
- Cutting edge: nucleotide binding oligomerization domain 1-dependent responses account for murine resistance against trypanosoma cruzi infection
- Resistance to Leishmania spp. is mediated by the inflammasome induced duo: IL- 1β and nitric oxide
- NOD1/NOD2/RIP2 signaling in response to non-peptidoglycan containing pathogen contribute to development of a TH1-biased response and resistance against L. major infection
- Interplay between reactive oxygen species and the inflammasome are crucial for restriction of Neospora caninum replication
- Apoptosis-associated speck–like protein containing a caspase recruitment domain inflammasomes mediate IL-1β response and host resistance to Trypanosoma cruzi infection
- IFN-γ plays a unique role in protection against low virulent Trypanosoma cruzi strain
- A parent-of-origin effect determines the susceptibility of a non-informative F1 population to Trypanosoma cruzi infection in vivo
Informações sobre o DOI: 10.1111/j.1476-5381.2009.00576.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
